Hospitalized Recurrent Deep Vein Thrombosis: Demographic, Clinical, and Laboratory Insights from a Single-Center Retrospective Study

Aim: This study aimed to analyze the demographic, clinical, and laboratory characteristics of hospitalized patients with recurrent deep vein thrombosis (rDVT) and to identify associated risk factors and treatment outcomes. Material and Methods: A retrospective review was conducted on 45 patients hospitalized with rDVT between October 2021 and October 2023.Patients with active cancer, hematological or rheumatological diseases, immunosuppression, or organ failure were excluded.Demographic data, clinical characteristics, venous Doppler imaging, and emergency laboratory results were analyzed.Patients were grouped based on proximal or distal thrombus location, infection burden, and hospital length of stay.Statistical analyses included Student's t-test, Mann-Whitney U test, and Spearman correlation. Results:The median age of the study population was 72 years, with a higher prevalence in males (55.6%).Key risk factors included major surgery within two years (40%), diabetes mellitus (37.8%), and hormone replacement therapy (22.2%).Proximal thrombus was identified in 51% of patients, with males predominantly affected, while females showed higher rates of distal thrombus.Median hospital stay was five days, and longer stays were associated with elevated inflammatory markers, including CRP and uric acid levels.A significant correlation between D-dimer and uric acid was observed (r=0.40,p=0.005).Dual therapy with low molecular weight heparin and rivaroxaban was more common in proximal thrombus cases. Conclusion:This study highlights the distinct clinical and laboratory characteristics of hospitalized rDVT patients, with gender-and location-specific differences influencing management strategies.The positive correlation between D-dimer and uric acid suggests a potential role of uric acid as a biomarker in resource-limited settings.Further research is warranted to address the genetic and hereditary aspects of rDVT.

Authors

Publication Details

Journal
Kafkas Journal of Medical Sciences
Published
2025-01-01
DOI
https://doi.org/10.5505/kjms.2025.04710
Primary Topic
Venous Thromboembolism Diagnosis and Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Hospitalized Recurrent Deep Vein Thrombosis: Demographic, Clinical, and Laboratory Insights from a Single-Center Retrospective Study

Turgut Dolanbay, Ömer Yüceer, Alpay Tuncar, Mustafa Oguz Cumaoğlu et al.
Kafkas Journal of Medical Sciences
Venous Thromboembolism Diagnosis and Management
article

Hospitalized Recurrent Deep Vein Thrombosis: Demographic, Clinical, and Laboratory Insights from a Single-Center Retrospective Study

Turgut Dolanbay, Ömer Yüceer, Alpay Tuncar, Mustafa Oguz Cumaoğlu, Abdussamed Vural, Seyyid Rasim Yanmaz
article en

Abstract

Aim: This study aimed to analyze the demographic, clinical, and laboratory characteristics of hospitalized patients with recurrent deep vein thrombosis (rDVT) and to identify associated risk factors and treatment outcomes. Material and Methods: A retrospective review was conducted on 45 patients hospitalized with rDVT between October 2021 and October 2023.Patients with active cancer, hematological or rheumatological diseases, immunosuppression, or organ failure were excluded.Demographic data, clinical characteristics, venous Doppler imaging, and emergency laboratory results were analyzed.Patients were grouped based on proximal or distal thrombus location, infection burden, and hospital length of stay.Statistical analyses included Student's t-test, Mann-Whitney U test, and Spearman correlation. Results:The median age of the study population was 72 years, with a higher prevalence in males (55.6%).Key risk factors included major surgery within two years (40%), diabetes mellitus (37.8%), and hormone replacement therapy (22.2%).Proximal thrombus was identified in 51% of patients, with males predominantly affected, while females showed higher rates of distal thrombus.Median hospital stay was five days, and longer stays were associated with elevated inflammatory markers, including CRP and uric acid levels.A significant correlation between D-dimer and uric acid was observed (r=0.40,p=0.005).Dual therapy with low molecular weight heparin and rivaroxaban was more common in proximal thrombus cases. Conclusion:This study highlights the distinct clinical and laboratory characteristics of hospitalized rDVT patients, with gender-and location-specific differences influencing management strategies.The positive correlation between D-dimer and uric acid suggests a potential role of uric acid as a biomarker in resource-limited settings.Further research is warranted to address the genetic and hereditary aspects of rDVT.

Kafkas Journal of Medical SciencesVol. 15(2)
Openalex Percentile: Top 60%
Venous Thromboembolism Diagnosis and Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.